Eight Versus Twelve Weeks of Sofosbuvir-Velpatasvir in Treatment-Naïve Non-Cirrhotic Patients with Chronic Hepatitis C Virus Infection: Study Protocol for a Multicentric, Open Labelled, Randomized, Non-Inferiority Trial (RESOLVE Trial).
PLOS ONE（2023）
关键词
Treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要